Our previous study demonstrated that although KRAS and BRAF mutations never coexisted within the same ovarian tumor, a defect in one of those genes was present in 6 out of 7 SBOTs examined with the Idylla Mutation Test [31]. The gene discussed is BRAF; the disease is ovarian neoplasm.